SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001849682-23-000004
Filing Date
2023-03-08
Accepted
2023-03-08 17:24:11
Documents
1
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167831424008442.html 4  
1 FORM 4 wf-form4_167831424008442.xml 4 4376
  Complete submission text file 0001849682-23-000004.txt   5972
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAREDX, INC. 1 TOWER PLACE, 9TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Dhingra Ankur (Reporting) CIK: 0001849682 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 23717250